ResearcherWest China Hospital of Sichuan UniversityNo recent work listed

Bole Tian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1611-5657. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. Last author DOI 10.1097/md.0000000000027103 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zuowei Wu · 1 shared paper, 2021 · strength 0.15
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103 ↗
Xing Huang · 1 shared paper, 2021 · strength 0.15
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103 ↗
Li Mao · 1 shared paper, 2021 · strength 0.15
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103 ↗
Chao Wu · 1 shared paper, 2021 · strength 0.15
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103 ↗
Zihe Wang · 1 shared paper, 2021 · strength 0.15
- Paper EUS-CGN versus EUS-CPN in pancreatic cancer: A qualitative systematic review. DOI 10.1097/md.0000000000027103 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.